PhenoTA

Company Overview

Snapshot

Founded in December 2023 by Shahar Karny, Eran Small, and Yoram Cohen, PhenoTA operates with 1–10 employees. The company has secured funding across one round from 2 investors, including Jibe Ventures. In January 2024, PhenoTA received seed funding to advance its novel technology and AI capabilities in blood cell analysis.

Business overview

PhenoTA is a Health Tech & Life Sciences company focused on transforming medical decision-making through advanced blood test insights. The company develops novel technology and applies advanced AI capabilities to blood cells, aiming to provide unparalleled health insights from routine blood tests. Operating in stealth mode, PhenoTA serves the healthcare industry, specifically targeting providers within the Healthcare & Life Sciences sector with its B2B business model.

Company Intelligence Q&A

When was PhenoTA founded?

PhenoTA was founded in December 2023.

Who are the founders of PhenoTA?

The co-founders of PhenoTA are Shahar Karny (Co-founder & CEO), Eran Small (Co-founder & CTO), and Yoram Cohen (Co-founder & VP R&D).

What is PhenoTA's primary sector?

PhenoTA's primary sector is Health Tech & Life Sciences, with a focus on Medical Devices and Artificial Intelligence as a core technology.

What is the current employee count for PhenoTA?

PhenoTA currently has 1–10 employees.